Maridea Wealth Management LLC Makes New Investment in Astera Labs, Inc. $ALAB

Posted by Geri Gentry on Aug 16th, 2026

Maridea Wealth Management LLC purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 4,231 shares of the company’s stock, valued at approximately $2,044,000.

Several other large investors also recently bought and sold shares of ALAB. Atreides Management LP lifted its position in shares of Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares in the last quarter. Amundi grew its holdings in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares in the last quarter. Artisan Partners Limited Partnership acquired a new stake in Astera Labs during the 4th quarter valued at $148,980,000. Goldman Sachs Group Inc. increased its stake in Astera Labs by 189.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after buying an additional 858,693 shares during the period. Finally, State Street Corp increased its stake in Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after buying an additional 760,358 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Activity at Astera Labs

In other news, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 686 shares of the stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total transaction of $270,997.44. Following the transaction, the director directly owned 5,550 shares in the company, valued at $2,192,472. The trade was a 11.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,256,894 shares of company stock worth $362,763,135 over the last quarter. Company insiders own 10.40% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective on the stock. TD Cowen lowered their target price on Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research note on Wednesday, August 5th. Evercore reaffirmed an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. Royal Bank Of Canada boosted their price target on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Finally, Needham & Company LLC increased their price target on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $325.25.

Read Our Latest Stock Analysis on ALAB

Astera Labs Trading Down 0.4%

ALAB stock opened at $321.61 on Friday. The firm has a 50 day simple moving average of $358.00 and a 200-day simple moving average of $240.20. The company has a market capitalization of $55.80 billion, a P/E ratio of 159.21 and a beta of 3.84. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48.

Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the prior year, the company posted $0.44 earnings per share. The firm’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.